[HTML] nih.gov

[HTML][HTML] Lipid nitroalkene nanoparticles for the focal treatment of ischemia reperfusion

ZY Gary, T Ramasamy, M Fazzari, X Chen… - …, 2022 - ncbi.nlm.nih.gov
Rationale: The treatment of microvascular obstruction (MVO) using ultrasound-targeted LNP
cavitation (UTC) therapy mechanically relieves the physical obstruction in the …
被引用次数：8 相关文章

Lipid nitroalkene nanoparticles for the focal treatment of ischemia reperfusion

ZY Gary, T Ramasamy, M Fazzari, X Chen… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Rationale: The treatment of microvascular obstruction (MVO) using ultrasound-targeted LNP
cavitation (UTC) therapy mechanically relieves the physical obstruction in the …
[HTML] ntno.org

[HTML][HTML] Lipid nitroalkene nanoparticles for the focal treatment of ischemia reperfusion

GZ Yu, T Ramasamy, M Fazzari, X Chen, B Freeman… - Nanotheranostics, 2022 - ntno.org
Methods: The stability and acoustic behavior of nitro-fatty acid LNP (NO 2-FA-LNP) were
characterized by HPLC-MS/MS and ultra-high-speed microscopy. The LNP were then used …

Lipid nitroalkene nanoparticles for the focal treatment of ischemia reperfusion.

GZ Yu, T Ramasamy, M Fazzari, X Chen… - …, 2022 - europepmc.org
Rationale: The treatment of microvascular obstruction (MVO) using ultrasound-targeted LNP
cavitation (UTC) therapy mechanically relieves the physical obstruction in the …

Lipid nitroalkene nanoparticles for the focal treatment of ischemia reperfusion.

GZ Yu, T Ramasamy, M Fazzari, X Chen… - …, 2022 - europepmc.org
Rationale: The treatment of microvascular obstruction (MVO) using ultrasound-targeted LNP
cavitation (UTC) therapy mechanically relieves the physical obstruction in the …